2024年合成生物及原料药产业研究中国合成生物学研发成果遍地开花，原料药产业迎来高质量发展新阶段

Investment Rating - The report does not explicitly state an investment rating for the synthetic biology and APIs industry Core Insights - The synthetic biology and APIs industry in China is experiencing rapid development, with significant advancements in technology and market potential across various sectors including agriculture, healthcare, and food [4][5] - The application of synthetic biology in the production of APIs addresses traditional challenges such as low capacity utilization and environmental pollution, thereby enhancing production efficiency and quality [6][12] - The industry is expected to contribute to sustainable development goals by promoting green manufacturing practices and optimizing production processes [5][6] Summary by Sections Industry Overview - Synthetic biology has become a crucial frontier in biotechnology, with applications spanning agriculture, healthcare, and food sectors, showcasing strong technological potential and market prospects [4] - The gap between China's synthetic biology development and advanced markets is narrowing, with a more complete industrial chain being formed [4][5] Development History - Since 2000, synthetic biology has rapidly evolved, with significant breakthroughs in basic technologies and large-scale applications, particularly in drug development and biomedical research [12][22] Application Scenarios - In agriculture, synthetic biology aids in the efficient and environmentally friendly production of pesticides and fertilizers, promoting green agriculture [6] - In healthcare, synthetic biology provides innovative solutions for drug development and production, enhancing drug quality and supply security [6][13] - The technology is also applied in the production of high-value food components, contributing to the food industry [6][12] Market Size and Growth - The global market for synthetic biology has seen rapid growth, with the healthcare sector being the largest and fastest-growing segment, projected to reach $11.84 billion by 2028 from $6.99 billion in 2023 [21][22] - The market for industrial chemicals and agricultural applications is also expanding significantly, indicating the broad potential of synthetic biology across various industries [21][22] Policy Environment - The Chinese government has implemented supportive policies to foster innovation and quality regulation in the synthetic biology sector, enhancing its development in biomedicine and agricultural chemicals [26][27] Supply and Demand in APIs - China's chemical API production has shown an upward trend, with a total output increasing from 2.304 million tons in 2018 to 3.936 million tons in 2023, driven by the need for seasonal disease treatments and public health emergencies [28][29] - The demand for APIs is expected to remain strong due to the rising burden of infectious diseases and chronic conditions among the population [31][32]